ARWR - Arrowhead Pharmaceuticals GAAP EPS of -$0.60 misses by $0.20 revenue of $27.4M misses by $23.64M February, 02 2022 04:10 PM Arrowhead Pharmaceuticals Inc. Arrowhead Pharmaceuticals press release (NASDAQ:ARWR): Q1 GAAP EPS of -$0.60 misses by $0.20. Revenue of $27.4M (+28.6% Y/Y) misses by $23.64M. For further details see: Arrowhead Pharmaceuticals GAAP EPS of -$0.60 misses by $0.20, revenue of $27.4M misses by $23.64M